Base excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cells

KRAS mutations in NSCLC are supposed to indicate a poor prognosis and poor response to anticancer treatments but this feature lacks a mechanistic basis so far. In tumors, KRAS was found to be mutated mostly at codons 12 and 13 and a pool of mutations differing in the base alteration and the amino ac...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Caiola, Elisa, Salles, Daniela, Frapolli, Roberta, Lupi, Monica, Rotella, Giuseppe, Ronchi, Anna, Garassino, Marina Chiara, Mattschas, Nikola, Colavecchio, Stefano, Broggini, Massimo, Wiesmüller, Lisa, Marabese, Mirko
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2015
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4745782/
https://ncbi.nlm.nih.gov/pubmed/26353932
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars